<SEC-DOCUMENT>0001193125-25-256667-index.html : 20251029
<SEC-HEADER>0001193125-25-256667.hdr.sgml : 20251029
<ACCEPTANCE-DATETIME>20251029171614
ACCESSION NUMBER:		0001193125-25-256667
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251029
DATE AS OF CHANGE:		20251029

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Virax Biolabs Group Ltd
		CENTRAL INDEX KEY:			0001885827
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94426
		FILM NUMBER:		251430979

	BUSINESS ADDRESS:	
		STREET 1:		BIOCITY GLASGOW
		STREET 2:		BO'NESS ROAD, NEWHOUSE
		CITY:			LANARKSHIRE
		STATE:			X0
		ZIP:			ML1 5UH
		BUSINESS PHONE:		44 020 7788 7414

	MAIL ADDRESS:	
		STREET 1:		BIOCITY GLASGOW
		STREET 2:		BO'NESS ROAD, NEWHOUSE
		CITY:			LANARKSHIRE
		STATE:			X0
		ZIP:			ML1 5UH

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virax Biolabs (Cayman) Ltd
		DATE OF NAME CHANGE:	20210930

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Foster James Alexander Cunliffe
		CENTRAL INDEX KEY:			0001988784
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	MAIL ADDRESS:	
		STREET 1:		20 NORTH AUDLEY STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 6LX
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>